Literature DB >> 11603126

N-acetyltransferase 2 phenotype in painters with bladder cancer and controls.

K Golka, W Weistenhofer, P Jedrusik, F Geller, M Blaszkewicz, H M Bolt.   

Abstract

AIM: This study was designed to evaluate the impact of N-acetyltransferase 2 (NAT2, substrate: aromatic amines) in painters with bladder cancer and controls.
BACKGROUND: Until the beginning of the 1960s, painters in Germany have used, among others, azo dyes based on carcinogenic aromatic amines.
MATERIALS AND METHODS: Sixteen painters with bladder cancer and 26 healthy painters (controls) who were from the same area in Germany and in the same age group (+/-5 years) were recruited into the study. All subjects were phenotyped for NAT2 by the molar ratio of two caffeine metabolites in the urine which was determined by the high performance liquid chromatography (HPLC) method. The number of years working as a painter, age at first exposure to paints and the life-time smoking habits of subjects were noted.
RESULTS: Fourteen cases and 23 controls had been exposed to paints before 1960. Age at first exposure to paint was 15.5 years (SD 5.3) in cases and 16.3 (SD 4.9) years in controls. Cases had worked 31.1 years (SD 15.0) and controls had worked 44.8 years (SD 7.2) as painters. Four cases and 7 controls were non-smokers. In this study, 88% of cases and 65% of controls were of the "slow" acetylation and phenotype,
CONCLUSION: The result point to and impact of the slow acetylation status as an individual risk factor for bladder cancer in persons occupationally exposed to amounts of carcinogenic aromatic amines released from water-soluble azo dyes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11603126

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  1 in total

Review 1.  Recent advances in the metabolomic study of bladder cancer.

Authors:  Chandra Sekhar Amara; Venkatrao Vantaku; Yair Lotan; Nagireddy Putluri
Journal:  Expert Rev Proteomics       Date:  2019-02-26       Impact factor: 3.940

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.